Trials / Completed
CompletedNCT00545259
Pharmacokinetic Study of AEB071 in Patients Following Liver Transplantation
An Open-label, Two-period, Multi-center, Single Dose Study to Assess the Pharmacokinetics of AEB071 in de Novo Liver Transplant Patients
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 13 (actual)
- Sponsor
- Novartis · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The study will evaluate the pharmacokinetic profile of AEB071 in the immediate post-transplant period in patients who have undergone their first liver transplant.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | AEB071 |
Timeline
- Start date
- 2007-10-01
- Primary completion
- 2009-02-01
- First posted
- 2007-10-17
- Last updated
- 2020-12-08
Locations
3 sites across 3 countries: Germany, Italy, Switzerland
Source: ClinicalTrials.gov record NCT00545259. Inclusion in this directory is not an endorsement.